Lutemax Kids, a low dose formulation of lutein and zeaxanthin isomers by OmniActive Health Technologies (OmniActive), has been associated with improvements in cognitive performance and eye health in school-aged children.
The results of the first-of-its-kind study were published in the journal Advances in Therapy, and expand upon the company’s earlier research into eye health in adults, including the LAMA I & LAMA II (Lutein, Vision and Mental Acuity), and B.L.U.E. (Blue Light User Exposure) studies.
“The study results demonstrated that Lutemax Kids supplementation contributes positively to aspects of eye health and cognitive performance in school-aged children, echoing the well-documented benefits observed in adults,” said Dr. Billy Hammond, Professor (Behavioral and Brain Sciences Program) at the University of Georgia and lead researcher in the study. “From improved visual processing speed to eye strain that may result from digital device use, these outcomes serve as a foundation for tailored supplementation in children. It also emphasizes the potential to help meet specific needs of children during a critical developmental phase.”
Study Details
In a randomised, double-blind, placebo-controlled trial that spanned 180 days, 60 healthy male and female children were given a daily dose of either Lutemax Kids, containing 10 mg lutein and 2 mg zeaxanthin isomers in a gummy format, or placebo.
The outcomes of the study support that over time supplementation with Lutemax Kids:
- Significantly increased blood levels of lutein and zeaxanthin
- Increased macular pigment optical density (M.P.O.D.) levels
- Increased visual processing speed
- Decreased eye strain and fatigue attributed to digital device usage
- Significantly improved aspects of cognitive health, including attention, focus, episodic memory, visuospatial memory, and visuospatial processing speed
“The insights from the study on lutein and zeaxanthin supplementation using Lutemax Kids are promising. Understanding the profound impact of these vital nutrients on young eyes and minds is a game changer, shedding light on their role in fostering well-being from an early age,” said Dr. Arun Balakrishnan, Chief Innovation Officer at OmniActive. “Our pioneering efforts with this study come at a critical time when supplement brands are looking to cater to children’s health and wellness needs with safe, plant-based, and efficacious ingredients. As we continue to see the benefits of lutein and zeaxanthin across all life stages, we’re reaffirming lutein and zeaxanthin’s significance in promoting a healthier future for our younger generation across the globe.”
Lutemax Kids, a line extension of OmniActive’s pioneering lutein and zeaxanthin extract brand Lutemax 2020, is a lower dose to help meet the nutritional needs of children. It was developed to deliver a clinically studied option to supplement brands needing ingredients for a younger demographic.
Last year, to further reinforce the need for children to consume a diet rich in lutein and zeaxanthin, OmniActive launched the “Lutein for Every Age” educational initiative. The survey found that six in ten parents regularly worry about their child’s eye health but are unfamiliar with ways to support it. Only one in ten shared that their children take a supplement daily.
To learn more about the study, Lutemax Kids, or the “Lutein for Every Age” initiative, visit Lutemax.com/lfea.
